ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2124

Mixed Connective Tissue Disorder Has Higher Prevalence of Arthritis and Use of Methotrexate Than Systemic Lupus Erythematosus

Gunasekaran Sambandam1,2, Dr. Varun Dhir3, Dr. Mahesh Prakash4, Ranjana Minz5, Shefali Sharma6 and Aman Sharma7, 1Internal Medicine, Post Graduate Institute of Medical Education and Research (PGIMER), chandigarh, India, 2Internal medicine, Post graduate Institute of medical education and research, chandigarh, India, 3Internal Medicine ( Clinical Rheumatology), Post Graduate Institute of Medical Education and Research, chandigarh, India, 4Radio Diagnosis, Post Graduate Institute of Medical Education and Research, chandigarh, India, 5Department of Immunopathology,, PGIMER,, Chandigarh, India, 6Department of Medicine, All India Institute of Medical Sciences, New Delhi, New Delhi, India, 7Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Arthritis, mixed connective tissue disease (MCTD) and systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 7, 2017

Title: Miscellaneous Rheumatic and Inflammatory Diseases Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Mixed connective disease is a multi-system disorder with overlapping features of SLE, rheumatoid arthritis, scleroderma and polymyositis/dermatomyositis with high titres of U1 RNP. Arthritis is a common manifestation that can be erosive and deforming. However, it is unclear whether clinical arthritis in MCTD is more common than SLE and there is little data comparing detection of synovitis by ultrasound in the two diseases.

Methods: In this cross-sectional study, we used the Kasukawa criteria for the diagnosis of MCTD and SLICC criteria for SLE patients. Patients were matched for gender and disease duration. U1-RNP was done in MCTD patients by Fluorescence Enzyme Immuno Assay in a 1:10 dilution and ANA by ELISA with a 1:200 dilution of sera. History of arthralgia/arthritis and clinical evaluation for swelling, tenderness, limitation of movements and deformities was done. Functional disability was assessed using the Indian Health assessment questionnaire.Hand radiographs of patients were assessed by for erosions. In addition, ultrasound (9-14 Mhz linear probe) of the non-dominant wrist, metacarpal joints for synovitis and teno-synovitis of flexor and extensor wrist compartments was assessed using the OMERACT definition.

Results: Forty patients were recruited in both groups, with similar gender distribution (F:M=38/2, 38/2), disease duration (3.7±2.3, 4.7±3.1, p=0.1) but slightly younger in age (31.8±13.3, 36±10.2, p=0.01) in MCTD than SLE. ANA was positive in all patients in both groups, and U1RNP was positive in all MCTD patients .History suggestive of inflammatory arthralgia/arthritis (100 vs 75%, p = 0.001) and current arthritis on examination (65 vs 37.5%, p=0.03) was significantly higher in MCTD than SLE (Table 1). PIP (30 vs 10%, p=0.025) and wrist (61.8vs 32.5%, p =0.007) involvement were significantly more in the MCTD. (Table 1) Use of methotrexate was also significantly more in the MCTD group(20% vs 5% p= 0.043). However, on Ultrasound there was no significant difference in presence of synovitis (p= 0.32) or teno-synovitis (p=0.51) and there was no difference in the functional disability measured by Indian Health assessment questionnaire (0.73 vs 0.74, p=0.7).Deformity was more common in MCTD (10 vs 0%), however, erosions were uncommon in both.Rheumatoid factor was positive more in patients with MCTD than SLE (34.4 vs 6.3%, p=0.005)

Conclusion: In this study we observed clinical arthritis to be significantly higher in MCTD patients in comparison with SLE, however, an equally high presence of synovitis on Ultrasound.

Table 1: clinical arthritis

Joints/ arthritis

MCTD (%)

SLE (%)

p value

Atleast one tender joint

65

37.5

0.014

Atleast one swollen joint

47.5

15

0.002

PIP

27.5

42.5

0.16

DIP

10

30

0.025

MCP

0

2.5

0.314

Wrist

32.5

61.8

0.007

Elbow

12.5

22.5

0.239

Shoulder

20

27.5

0.431

Hip

0

0

–

Knee

15

10

0.499

Ankle

12.5

12.5

1.0

MTP

5

7.5

0.644

IP

0

0

–


Disclosure: G. Sambandam, None; D. V. Dhir, None; D. M. Prakash, None; R. Minz, None; S. Sharma, None; A. Sharma, None.

To cite this abstract in AMA style:

Sambandam G, Dhir DV, Prakash DM, Minz R, Sharma S, Sharma A. Mixed Connective Tissue Disorder Has Higher Prevalence of Arthritis and Use of Methotrexate Than Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/mixed-connective-tissue-disorder-has-higher-prevalence-of-arthritis-and-use-of-methotrexate-than-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/mixed-connective-tissue-disorder-has-higher-prevalence-of-arthritis-and-use-of-methotrexate-than-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology